By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PregLem SA 

Chemin des Aulx, 12

Plan-les-Ouates  Geneva  1228  Switzerland
Phone: 41-0-22-884-03-40 Fax: 41-0-22-884-03-49


Start Up

Company News
Watson Pharmaceuticals, Inc. (WPI) and Gedeon Richter (RIG2.F) Announce Exclusive License Agreement with PregLem SA for Esmya(TM); Watson to pay PregLem $17M 12/16/2010 6:39:38 AM
Ipsen Sells its Shares in PregLem SA to Gedeon Richter Ltd. 10/11/2010 12:21:14 PM
Richter International, Inc. Buys Swiss PregLem SA for up to $461 Million 10/8/2010 7:53:52 AM
PregLem SA Announces In-Licensing Deal With Merck Serono For Post-Operative Adhesions & Endometriosis 8/11/2010 8:26:29 AM
PregLem SA Said to Hire Credit Suisse for Possible Initial Public Offering 7/9/2010 8:47:46 AM
PregLem SA Announces Positive Phase III Results for Esmya(TM) 6/3/2010 6:47:26 AM
PregLem SA Announces Positive Phase 3 Results For Esmya(TM) as an Effective Treatment For Uterine Fibroids; PEARL II Study Meets Both Primary Efficacy and Safety Endpoints 5/19/2010 9:03:50 AM
PregLem SA Presenting At JP Morgan Healthcare Conference 1/12/2010 8:13:15 AM
PregLem SA Announces The Appointment Of Dr Suhail Nurbhai As Chief Medical Officer 6/2/2009 3:32:42 PM
Fritz Kunz Joins PregLem SA's Board of Directors 9/9/2008 2:26:13 PM